 ENGLEWOOD, Colo., July 29, 2021 PRNewswire -- Ampio Pharmaceuticals NYSE American: AMPE, a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced details on the Companys poster presentation, Efficient Applied Toxicology during COVID-19: A Preclinical Study that Advanced Clinical Use of Ampion, being given virtually at the American College of Toxicology 42nd Annual Meeting, November 14 to 17, 2021, at the Gaylord National Harbor in Washington, DC. 